Tag: Technology

Displaying 221 - 240 of 322 results.

The Federal Trade Commission staff today sent warning letters to 34 Web site operators making claims that products advertised as natural alternatives to hormone replacement therapy will prevent or treat diseases, such as cancer, heart disease, or osteoporosis. The warning letters advise these...
Two consent orders announced by the Federal Trade Commission today both resolve the competitive concerns about Chevron Corporation’s (Chevron) proposed $18 billion acquisition of Unocal Corporation (Unocal), and settle the Commission’s 2003 monopolization complaint against Unocal alleging...
The Federal Trade Commission and Spain’s Agencia Española de Protección de Datos (AEPD) today signed a bilateral Memorandum of Understanding (MOU) to promote enhanced cooperation and information-sharing on spam enforcement activities. Officials from both agencies will cooperate to address the...
In this amicus brief in support of Teva’s combined petition for rehearing and rehearing en banc, the Commission argues that the court erred in affirming the district court’s dismissal of Teva’s complaint in this Hatch-Waxman Act case. The brief argues that the court applied the wrong...
In February and March 2005, the Federal Trade Commission, the National Academies’ Board on Science, Technology, and Economic Policy (STEP), and the American Intellectual Property Law Association (AIPLA) will co-sponsor a nationwide series of town meetings on patent reform. The first three meetings...
The attorneys general of several states (the States) today announced their submission, for approval by the U.S. District Court for the District of New Jersey, of a settlement agreement with Akzo Nobel, N.V., and its subsidiary, Organon USA Inc. (collectively, Organon), resolving the States'...
The Federal Trade Commission will host a public workshop, “Peer-to-Peer File-Sharing Technology: Consumer Protection and Competition Issues,” to explore consumer protection and competition issues associated with the distribution and use of peer-to-peer (P2P) file-sharing. The workshop will be held...
Petition to reopen and modify final order: The Commission has received an application from Liberty Media Corporation (Liberty) requesting that the FTC reopen and modify the final order in the matter of Time Warner, Inc., et al. (Docket No. C-3709), as it applies to Liberty and its continuing...
The consent order settled charges that Cephalon's proposed acquisition of Cima Labs, Inc. would allow Cephalon to continue its monopoly in the United States market for drugs that eliminate or reduce the spikes of severe pain that chronic cancer patients experience. The consent order...
Joint brief of the United States and the Federal Trade Commission, urging the Court to deny a writ of certiorari in this case, regarding private patent litigation and the legal standards applicable to “reverse payment” patent litigation settlements in the Hatch-Waxman context...
The Federal Trade Commission today reinstated charges that the Union Oil Company of California violated antitrust laws by defrauding the California Air Resources Board (CARB) in connection with regulatory proceedings regarding development of reformulated gasoline.
Law enforcers from the United States, United Kingdom, and Australia announced today that they will join forces and share resources to fight illegal spam. A Memorandum of Understanding between the U.S. Federal Trade Commission, the U.K. Office of Fair Trading, the U.K.
The consent order, designed to preserve competition in the market for the manufacture and sale of mobile radio frequency automatic meter reading technologies for electric utilities in the United States, permitted Itron's $255 million acquisition of Schlumberger Electricity, Inc. The...
On April 15 and 16, 2004, the Federal Trade Commission, the National Academy of Sciences (NAS), and the Berkeley Center for Law and Technology will co-sponsor a conference to address patent reform and how it might be implemented. The event will bring together government officials, business...
The Commission argues that the district court erred by dismissing Teva's complaint against Pfizer in this Hatch-Waxman Act case. Teva sought a declaratory judgment that its generic version of sertraline hydrochloride would not infringe a patent held by Pfizer (or that the patent was...

Pages